[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100610121":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":28,"centralContacts":32,"locations":37,"responsibleParty":87,"collaborators":89,"id":98,"slug":24,"hasResults":99,"nctId":100,"briefTitle":101,"officialTitle":101,"acronym":24,"eligibilityCriteria":102,"healthyVolunteers":99,"sex":103,"minAge":104,"maxAge":105,"enrollmentInfo":106,"targetDuration":24,"studyType":109,"phases":110,"briefSummary":112,"conditions":113,"keywords":116,"overallStatus":120,"whyStopped":24,"lastUpdateSubmitDate":121,"lastUpdatePostDateStruct":122,"startDateStruct":125,"completionDateStruct":127,"leadSponsor":129,"locationsCount":130},{"fullName":5,"class":6},"Children's Hospital Medical Center, Cincinnati","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Tailored Program","EXPERIMENTAL","8-week program including 4 coach visits and 4 text check-ins",[13],"Behavioral: Tailored Program",{"label":15,"type":6,"description":16,"interventionNames":17},"Feedback Program (Uniform Standard of Care)","8-week feedback program including weekly texts",[18],"Behavioral: Feedback Program (Uniform Standard of Care)",[20,25],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":24},"BEHAVIORAL","Participants will participate in 4 sessions with a coach, 1 every other week. During these sessions, the participant will work with their coach to identify a barrier to adherence they would like to target. Then, they will work with their coach to create an action plan using evidence-based behavior change techniques to address this barrier. In between sessions (on alternating weeks), the coach will check-in with a text reminder about the plan.",[9],null,{"type":21,"name":15,"description":26,"armGroupLabels":27,"otherNames":24},"Participants will receive weekly text messages with feedback about their adherence and guidance for requesting additional support if desired",[15],[29],{"name":30,"affiliation":5,"role":31},"Meghan E. McGrady, PhD","PRINCIPAL_INVESTIGATOR",[33],{"name":30,"role":34,"phone":35,"phoneExt":24,"email":36},"CONTACT","513-803-8044","Meghan.McGrady@cchmc.org",[38,54,67,77],{"facility":39,"status":24,"city":40,"state":41,"zip":42,"country":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"The University of Kansas Medical Center","Kansas City","Kansas","66160","United States",{"type":45,"coordinates":46},"Point",[47,48],-94.62746,39.11417,{"lat":48,"lon":47},[51],{"name":52,"role":34,"phone":24,"phoneExt":24,"email":53},"Carolyn Bates, PhD","cbates4@kumc.edu",{"facility":55,"status":24,"city":56,"state":56,"zip":57,"country":43,"cosmosGeoPoint":58,"geoPoint":62,"contacts":63},"Columbia University Irving Medical Center","New York","1003230702",{"type":45,"coordinates":59},[60,61],-74.00597,40.71427,{"lat":61,"lon":60},[64],{"name":65,"role":34,"phone":24,"phoneExt":24,"email":66},"Melissa Beauchemin, PhD","mmp2123@cumc.columbia.edu",{"facility":68,"status":24,"city":69,"state":70,"zip":71,"country":43,"cosmosGeoPoint":72,"geoPoint":76,"contacts":24},"Cincinnati Children's Hospital Medical Center","Cincinnati","Ohio","45229",{"type":45,"coordinates":73},[74,75],-84.51439,39.12711,{"lat":75,"lon":74},{"facility":78,"status":24,"city":79,"state":80,"zip":81,"country":43,"cosmosGeoPoint":82,"geoPoint":86,"contacts":24},"Seattle Children's Hospital","Seattle","Washington","98105",{"type":45,"coordinates":83},[84,85],-122.33207,47.60621,{"lat":85,"lon":84},{"type":88,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR",[90,93,94,96],{"name":91,"class":92},"National Cancer Institute (NCI)","NIH",{"name":78,"class":6},{"name":95,"class":6},"University of Kansas Medical Center",{"name":97,"class":6},"Columbia University","100610121",false,"NCT07223463","A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer","Inclusion Criteria:\n\n* Patient is 15.00 to 24.99 years of age\n* Patient is diagnosed with cancer\n* Patient is prescribed an oral anticancer\u002Fantitumor agent or prophylaxis\n\nExclusion Criteria:\n\n* Patient is not fluent in English\n* Patient evidences significant cognitive deficits\n* Patient's medical status or treatment precludes participation\n* Patient enrolled on a medical trial requiring medication storage in a trial-provided container\n* Patient demonstrates greater than or equal to 95% adherence during run-in period\n* Patient declines to use or has difficulty using electronic adherence monitoring device during run-in","ALL","15 Years","24 Years",{"count":107,"type":108},160,"ESTIMATED","INTERVENTIONAL",[111],"NA","The goal of this clinical trial is to learn if a tailored intervention can help make it easier for adolescents and young adults with cancer to take their medications. The main questions the researchers are trying to answer are:\n\n* Does the tailored intervention increase adherence?\n* Does the tailored intervention improve quality of life?\n* Does the tailored intervention reduce health care utilization?\n\nThe researchers will compare the tailored intervention to a uniform standard of care intervention (an intervention designed to be similar to what is currently happening in clinical care) to see if the tailored intervention works to improve adherence.\n\nParticipants will:\n\n* Use an electronic pill bottle or box to store their medication\n* Participate in intervention sessions\n* Complete surveys before the intervention, after the intervention, and 6-months later",[114,115],"Cancer","Medication Adherence",[117,118,119],"adolescents and young adults","cancer","adherence","NOT_YET_RECRUITING","2026-06-23",{"date":123,"type":124},"2026-06-24","ACTUAL",{"date":126,"type":108},"2026-09-01",{"date":128,"type":108},"2030-08-31",{"name":5,"class":6},4]